Rocket One (RKTO) Accumulated Expenses (2017 - 2026)
Rocket One's (RKTO) quarterly Accumulated Expenses came in at $379786.0 in Q2 2026, up 41.82% year-over-year from $267794.0 in Q2 2025, and up 61.89% quarter-over-quarter from $234592.0 in Q1 2026.
Analysis
Rocket One (RKTO) Accumulated Expenses (2017 - 2026) Analysis & Trends
Rocket One has disclosed Accumulated Expenses across 10 years of filings, most recently posting $379786.0 for Q2 2026.
- In Q2 2026, Accumulated Expenses rose 41.82% year-over-year to $379786.0; the TTM figure through Jun 2026 stood at $379786.0 (up 41.82% YoY), while the FY2025 annual figure was $623323.0, up 59.52% from the prior year.
- Accumulated Expenses came in at $379786.0 for Q2 2026 at Rocket One, up from $234592.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $1.2 million in Q2 2023 to a low of $45952.0 in Q1 2022.
- Average Accumulated Expenses over 5 years is $424827.1, with a median of $348598.0 recorded in 2024.
- Year-over-year, Accumulated Expenses slumped 84.46% in 2022 and surged 2258.26% in 2023.
- Over 5 years, Accumulated Expenses stood at $667742.0 in 2022, then retreated by 8.01% to $614226.0 in 2023, then slumped by 36.38% to $390760.0 in 2024, then surged by 59.52% to $623323.0 in 2025, then slumped by 39.07% to $379786.0 in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $379786.0 in Q2 2026, $234592.0 in Q1 2026, and $623323.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 379,786.00 |
| Mar 31, 2026 | 234,592.00 |
| Dec 31, 2025 | 623,323.00 |
| Sep 30, 2025 | 599,018.00 |
| Jun 30, 2025 | 267,794.00 |
| Mar 31, 2025 | 317,031.00 |
| Dec 31, 2024 | 390,760.00 |
| Sep 30, 2024 | 274,417.00 |
| Jun 30, 2024 | 317,410.00 |
| Mar 31, 2024 | 249,608.00 |
| Dec 31, 2023 | 614,226.00 |
| Sep 30, 2023 | 871,684.00 |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 530,103.00 |
| Dec 31, 2022 | 667,742.00 |
| Sep 30, 2022 | 52,502.00 |
| Jun 30, 2022 | 49,260.00 |
| Mar 31, 2022 | 45,952.00 |
| Dec 31, 2021 | 426,823.00 |
| Sep 30, 2021 | 217,771.00 |